Hematology Diagnostics Market 2018-2026: Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, Drew Scientific and Others

Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Pune, India -- (SBWire) -- 02/05/2019 --The global hematology diagnostics market was valued around US$ 3.51 Bn in 2017 and is anticipated to expand at a stable CAGR above 5.8% during the forecast period 2018 to 2026. According to the report titled "Hematology Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018-2026". Growing Rise in prevalence of blood disorders, increase in consolidation among market players and diagnostic laboratories, introduction of fully automated hematology analyzers and rapid technological advancements have increased the growth of the global hematology diagnostics market. The market in the North America is likely to expand at significant CAGR due to ease of usage, numerous technological advancements in instruments, and favourable reimbursement scenario.

Consumables segment is expected to register the highest growth rate during the forecast period

The global hematology diagnostics market is divided on the basis of product, test type, and end-user. By product type the hematology diagnostics market, categorized into instruments and consumables. Consumables segment contributed highest market share in 2017 and anticipated to maintain its dominance throughout the forecast period due to increased demand for consumables as incidences of blood disorders and other infections are increased. Growing use of microfluidics technology and introduction of digital imaging systems in hematology laboratories are expected to create opportunities for growth of the global hematology diagnostics market. Factors such as escalating adoption of POC testing hematology products in rising economies, introduction of innovatively propelled hematology items combined with the expanding inclination towards automation are driving the growth of the market. Moreover, the rising availability of wide range of consumables is boosting the growth of the consumable segment. Additionally, instruments category includes fully-automated hematology analyzers and semi-automated hematology analyzers. Growing automation and technological advancements are some of the fundamental factors that are fueling the growth of instruments segment.

Download Report Sample Pages For better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/935

Increasing incidences of blood disorder diseases is expected to propel the growth of blood count test type segment

Based on test type, the global hematology diagnostics market is bifurcated as blood count, platelet function, hemoglobin and hematocrit. Among these test types, blood count segment is projected to witness fast growth throughout the forecast period owing to the growing cases of blood disorder diseases, rising demand for improved healthcare facilities, increasing aging population and various clinical advancements, rise in demand for preventive diagnosis and treatment monitoring and growing automation are escalating the demand for blood count tests, thereby increasing the growth of the segment.

Constantly increasing geriatric population and sophisticated technological facilities in North America to create more opportunities in the global market

Geographically, the global hematology diagnostics market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2017, North America was estimated the biggest revenue generating region of the market. This growth is attributed to the rising frequency of patients experiencing blood issue, developing predominance of target sicknesses, rising interest for blood transfusions expanding the interest for hematology testing in the region. North America is anticipated to grow at significant CAGR over the forecast period. Asia Pacific is also expected to grow at significant rate during the forecast period owing to the large population and growing awareness towards health issues among people. Factors such as increasing awareness towards health problems, rising disposable income and increased utilization of diagnostic and therapy products. Due to growing automation in the healthcare equipment and increasing expenditure, Europe hematology diagnostics market is anticipated to be on rise in coming years. Regions such as Middle East and Africa and Latin America are also expected to contribute significant revenue share in 2026.

Key Players

The company profiling of key players in the global hematology diagnostics market includes company overview, major business strategies and revenues. The key players of the market are Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc. Industry participant battle on the basis of price, new innovated product launch, and expanding market presence.

VIEW DETAIL REPORT WITH COMPLETE TOC@ https://www.acumenresearchandconsulting.com/hematology-diagnostics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Hematology Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Hematology Diagnostics Market By Product
1.2.2.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Hematology Diagnostics Market Revenue Share By Product in 2017
1.2.2.3. Instrument
1.2.2.4. Consumables
1.2.2.5. Reagents
1.2.2.6. Stains
1.2.2.7. Others
1.2.3. Hematology Diagnostics Market By Test Type
1.2.3.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.3.2. Blood count
1.2.3.3. Platelet function
1.2.3.4. Hemoglobin
1.2.3.5. Hematocrit
1.2.3.6. Others
1.2.4. Hematology Diagnostics Market By End Users
1.2.4.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Diagnostic Labs
1.2.4.4. Others
1.2.5. Hematology Diagnostics Market by Geography
1.2.5.1. Global Hematology Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Hematology Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Diagnostic Labs Production Date of Global Hematology Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Hematology Diagnostics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Hematology Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Hematology Diagnostics Major Manufacturers in 2017

CHAPTER 4. HEMATOLOGY DIAGNOSTICS MARKET BY PRODUCT

4.1. Global Hematology Diagnostics Revenue By Product
4.2. Instrument
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Consumables
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Reagents
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Stains
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HEMATOLOGY DIAGNOSTICS MARKET BY TEST TYPE

5.1. Global Hematology Diagnostics Revenue By Test Type
5.2. Blood count
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Platelet function
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Hemoglobin
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Hematocrit
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HEMATOLOGY DIAGNOSTICS MARKET BY END USERS

6.1. Global Hematology Diagnostics Revenue By End Users
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Diagnostic Labs
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

7.1. North America Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Hematology Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

8.1. Europe Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

9.1. Asia-Pacific Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

10.1. Latin America Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

11.1. Middle East Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA HEMATOLOGY DIAGNOSTICS MARKET BY COUNTRY

12.1. Africa Hematology Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Hematology Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Abbott Laboratories
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Ortho Clinical Diagnostics
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Sysmex Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Boule Diagnostics
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. F. Hoffmann-La Roche Ltd.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Drew Scientific
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Bio-Rad Laboratories
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. EKF Diagnostics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Beckman Coulter, Inc
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/935

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report @ https://www.acumenresearchandconsulting.com/buy-now/0/935

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Media Relations Contact

Prashant K
https://www.acumenresearchandconsulting.com

View this press release online at: http://rwire.com/1137879